Starboard Activist Hedge Fund Appoints Five Directors to Bristol-Myers Board of Directors



1 hour ago

David Faber, CNBC, presents the latest news regarding the acquisition of Celgene by Bristol-Myers. In a press release, the company announced the convening of a special shareholders' meeting in April to decide on the Celgene deal. The hedge fund activist Starboard Value, which holds about $ 50 million worth of shares, announced that it had appointed five directors to the board of directors of the company for its annual meeting.


Source link